Authors:
FLEURY S
DEBOER RJ
RIZZARDI GP
WOLTHERS KC
OTTO SA
WELBON CC
GRAZIOSI C
KNABENHANS C
SOUDEYNS H
BART PA
GALLANT S
CORPATAUX JM
GILLET M
MEYLAN P
SCHNYDER P
MEUWLY JY
SPREEN W
GLAUSER MP
MIEDEMA F
PANTALEO G
Citation: S. Fleury et al., LIMITED CD4(-CELL RENEWAL IN EARLY HIV-1 INFECTION - EFFECT OF HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY() T), Nature medicine, 4(7), 1998, pp. 794-801
Authors:
PANTALEO G
COHEN OJ
SCHACKER T
VACCAREZZA M
GRAZIOSI C
RIZZARDI GP
KAHN J
FOX CH
SCHNITTMAN SM
SCHWARTZ DH
COREY L
FAUCI AS
Citation: G. Pantaleo et al., EVOLUTIONARY PATTERN OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION AND DISTRIBUTION IN LYMPH-NODES FOLLOWING PRIMARY INFECTION - IMPLICATIONS FOR ANTIVIRAL THERAPY, Nature medicine, 4(3), 1998, pp. 341-345
Authors:
RIZZARDI GP
MARRIOTT JB
COOKSON S
LAZZARIN A
DALGLEISH AG
BARCELLINI W
Citation: Gp. Rizzardi et al., TUMOR-NECROSIS-FACTOR (TNF) AND TNF-RELATED MOLECULES IN HIV-1(- RELATIONSHIP WITH IN-VITRO TH1() INDIVIDUALS )TH2-TYPE RESPONSE/, Clinical and experimental immunology, 114(1), 1998, pp. 61-65
Authors:
RIZZARDI GP
TAMBUSSI G
BARCELLINI W
CAPILUPPI B
CLERICI E
LAMAESTRA L
LILLO F
PANTALEO G
LAZZARIN A
Citation: Gp. Rizzardi et al., SOLUBLE CD30, TUMOR-NECROSIS-FACTOR (TNF)-ALPHA, AND TNF RECEPTORS INPRIMARY HIV-1 INFECTION - RELATIONSHIP WITH HIV-1 RNA, CLINICAL OUTCOME AND EARLY ANTIVIRAL THERAPY, Journal of biological regulators and homeostatic agents, 11(1-2), 1997, pp. 43-49
Authors:
MORAWETZ RA
RIZZARDI GP
GLAUSER D
RUTSCHMANN O
HIRSCHEL B
PERRIN L
OPRAVIL M
FLEPP M
VONOVERBECK J
GLAUSER MP
GHEZZI S
VICENZI E
POLI G
LAZZARIN A
PANTALEO G
Citation: Ra. Morawetz et al., GENETIC-POLYMORPHISM OF CCR5 GENE AND HIV DISEASE - THE HETEROZYGOUS (CCR5 DELTA-CCR5) GENOTYPE IS NEITHER ESSENTIAL NOR SUFFICIENT FOR PROTECTION AGAINST DISEASE PROGRESSION/, European Journal of Immunology, 27(12), 1997, pp. 3223-3227
Authors:
BARCELLINI W
RIZZARDI GP
BORGHI MO
NICOLETTI F
FAIN C
DELPAPA N
MERONI PL
Citation: W. Barcellini et al., IN-VITRO TYPE-1 AND TYPE-2 CYTOKINE PRODUCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - LACK OF RELATIONSHIP WITH CLINICAL-DISEASE ACTIVITY, Lupus, 5(2), 1996, pp. 139-145
Authors:
KNIGHT BC
SOUBERBIELLE BE
RIZZARDI GP
BALL SE
DALGLEISH AG
Citation: Bc. Knight et al., ALLOGENEIC MURINE MELANOMA CELL VACCINE - A MODEL FOR THE DEVELOPMENTOF HUMAN ALLOGENEIC CANCER VACCINE, Melanoma research, 6(4), 1996, pp. 299-306
Authors:
BARCELLINI W
RIZZARDI GP
POLI G
TAMBUSSI G
VELATI C
MERONI PL
DALGLEISH AG
LAZZARIN A
Citation: W. Barcellini et al., CYTOKINES AND SOLUBLE RECEPTOR CHANGES IN THE TRANSITION FROM PRIMARYTO EARLY CHRONIC HIV TYPE-1 INFECTION, AIDS research and human retroviruses, 12(4), 1996, pp. 325-331
Authors:
BARCELLINI W
RIZZARDI GP
MARRIOTT JB
FAIN C
SHATTOCK RJ
MERONI PL
POLI G
DALGLEISH AG
Citation: W. Barcellini et al., INTERLEUKIN-10-INDUCED HIV-1 EXPRESSION IS MEDIATED BY INDUCTION OF BOTH MEMBRANE-BOUND TUMOR-NECROSIS-FACTOR (TNF)-ALPHA AND TNF RECEPTOR-TYPE1 IN A PROMONOCYTIC CELL-LINE, AIDS, 10(8), 1996, pp. 835-842
Authors:
RIZZARDI GP
BROWN L
SOUBERBIELLE BE
DALGLEISH AG
Citation: Gp. Rizzardi et al., AN ALTERNATIVE TO CR-51 RELEASE ASSAY FOR MEASUREMENT OF NATURAL-KILLER ACTIVITY IN HIV-INFECTED PATIENTS, AIDS, 10(6), 1996, pp. 676-678
Authors:
RIZZARDI GP
BARCELLINI W
TAMBUSSI G
LILLO F
Citation: Gp. Rizzardi et al., PLASMA-LEVELS OF SOLUBLE CD30, TUMOR-NECROSIS-FACTOR (TNF)-ALPHA AND TNF RECEPTORS DURING PRIMARY HIV-1 INFECTION - CORRELATION WITH HIV-1 RNA AND THE CLINICAL OUTCOME, AIDS, 10(13), 1996, pp. 45-50
Authors:
RIZZARDI GP
LAZZARIN A
MUSICCO M
FRIGERIO D
MAILLARD M
LUCCHINI M
MORONI M
Citation: Gp. Rizzardi et al., RISKS AND BENEFITS OF AEROSOLIZED PENTAMIDINE AND COTRIMOXAZOLE IN PRIMARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN HIV-1-INFECTED PATIENTS - A 2-YEAR ITALIAN MULTICENTRIC RANDOMIZED CONTROLLED TRIAL, The Journal of infection, 32(2), 1996, pp. 123-131
Authors:
SHATTOCK RJ
RIZZARDI GP
HAYES P
GRIFFIN GE
Citation: Rj. Shattock et al., ENGAGEMGNT OF ADHESION MOLECULES (CD18, CD11A, CD45, CD44, AND CD58) ENHANCES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN MONOCYTIC CELLS THROUGH A TUMOR NECROSIS FACTOR-MODULATED PATHWAY, The Journal of infectious diseases, 174(1), 1996, pp. 54-62
Authors:
BARCELLINI W
RIZZARDI GP
VELATI C
BORGHI MO
FAIN C
LAZZARIN A
MERONI PL
Citation: W. Barcellini et al., IN-VITRO PRODUCTION OF TYPE-1 AND TYPE-2 CYTOKINES BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIGH-RISK HIV-NEGATIVE INTRAVENOUS-DRUG-USERS, AIDS, 9(7), 1995, pp. 691-694
Authors:
RIZZARDI GP
LAZZARIN A
MUSICCO M
FRIGERIO D
MAILLARD M
LUCCHINI M
MORONI M
AIUTI F
DOFFIZI GP
CAMPITELLI G
CADROBBI P
CRIVELLARO C
GAVA G
SATTIN A
CALONGHI G
BARCHI E
GAFA M
CAPUTO R
CARMINATI G
TARANTINI G
ZERBONI R
CARGNEL A
MEZZENZANA MA
CAROSI G
CHIODERA A
ELHAMAD I
JANNELLI J
CHIODO F
COLANGELI V
DELALLA F
VAGLIA A
FASSIO PG
GAVAZZENI G
ARICI C
FINAZZI MG
GIANNELLI F
ORSO M
VOLONTERIO A
GIANNINI V
ARMIGNACCO O
GUARIGLIA P
GRITTI FM
MAZZETTI M
MANNUCCI PM
GRINGERI A
SIMONI D
MANZILLO G
IZZO C
MANZILLO E
MILAZZO F
ARGENTERI B
CAPETTI A
ORTONA L
ANTINORI A
TAMBURRINI E
PACI P
DIPIETRO M
PAGANO G
PASTORE G
ANGARANO G
CONGEDO P
PIAZZA M
CHIRIANNI A
DABBRACCIO M
NOCE S
SCALISE G
ANCARANI F
PETRONI S
SORICE F
CIRELLI A
SALOTTI A
SUERI L
PARANINFO G
TIRELLI U
CROSATO I
VISCO G
ALBA L
GRISETTI S
TOCCI G
Citation: Gp. Rizzardi et al., BETTER EFFICACY OF TWICE-MONTHLY THAN MONTHLY AEROSOLIZED PENTAMIDINEFOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - AN ITALIAN MULTICENTRIC RANDOMIZED CONTROLLED TRIAL, The Journal of infection, 31(2), 1995, pp. 99-105
Authors:
BARCELLINI W
RIZZARDI GP
BORGHI MO
FAIN C
LAZZARIN A
MERONI PL
Citation: W. Barcellini et al., TH1 AND TH2 CYTOKINE PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLSFROM HIV-INFECTED PATIENTS, AIDS, 8(6), 1994, pp. 757-762
Authors:
BARCELLINI W
SACERDOTE P
BORGHI MO
RIZZARDI GP
FAIN C
MORGHEN CD
MANFREDI B
LAZZARIN A
MERONI PL
PANERAI AE
ZANUSSI C
Citation: W. Barcellini et al., BETA-ENDORPHIN CONTENT IN HIV-INFECTED HUT78 CELL-LINE AND IN PERIPHERAL LYMPHOCYTES FROM HIV-POSITIVE SUBJECTS, Peptides, 15(5), 1994, pp. 769-775